Zdrowie i gospodarka · 21/06/2018

FDA Announces Draft Guidance for Developing Antidepressant Drugs for Major Depressive Disorder Treatment

The US Food and Drug Administration (FDA) has released a draft guidance document to help pharmaceutical companies develop new treatments for major depressive disorder (MDD), a condition that affects millions of Americans, and is expected to be a key area of focus for the agency in the coming months.